Company Filing History:
Years Active: 2006-2016
Title: Christopher Jones: Innovator in Bioreactor Technology
Introduction
Christopher Jones is a notable inventor based in Cardiff, GB. He has made significant contributions to the field of bioreactor technology, holding 2 patents that enhance the efficiency of cell culture processes. His work is particularly relevant in the context of growing adherent mammalian cells, which are crucial for various biotechnological applications.
Latest Patents
One of his latest patents is titled "Method and apparatus for maintaining microcarrier beads in suspension." This invention relates to an impeller designed for use in a bioreactor, aimed at improving the growth of adherent mammalian cells. The impeller efficiently lifts a bed of settled cells and microcarrier beads at low rotational speeds, thereby enhancing cell growth while maintaining a low shear force environment.
Another significant patent is the "Fluorescence reference plate." This multi-modality fluorescence reference plate comprises wells coated with a fluorogenic compound. It serves the purpose of calibrating fluorescent plate readers and imaging systems, allowing for accurate measurements of various fluorescence parameters.
Career Highlights
Christopher Jones is currently employed at GE Healthcare UK Limited, where he continues to innovate in the field of bioreactor technology. His work has implications for improving bioprocessing techniques, which are essential for the production of biopharmaceuticals and other biological products.
Collaborations
Throughout his career, Christopher has collaborated with notable colleagues, including Philip John Meyler and Robert Arnold Jessop. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Christopher Jones is a prominent figure in the realm of bioreactor technology, with a focus on enhancing cell culture processes through innovative inventions. His contributions are vital for the advancement of biotechnological applications, and his patents reflect his commitment to improving efficiency in this field.